Literature DB >> 23980760

Mycobacterium tuberculosis bacteraemia: experience from a non-endemic urban centre.

H M El Sahly1, L D Teeter, J M Musser, E A Graviss.   

Abstract

The isolation of Mycobacterium tuberculosis from blood culture specimens has been associated with human immunodeficiency virus (HIV) co-infection with variable impact on tuberculosis (TB) mortality reported. The overwhelming majority of M. tuberculosis bacteraemia cases were described in developing countries. We present a nested case-control analysis of clinical, sociodemographic and behavioural risk factors in patients with positive M. tuberculosis blood cultures compared with patients with negative blood cultures from a 9-year population-based active TB surveillance study conducted in Houston, Texas. There were 42 patients with M. tuberculosis bacteraemia, 47 blood culture negative patients and 3573 patients for whom no mycobacterial blood culture was requested. HIV infection was more common in patients for whom a mycobacterial blood culture was requested (79.8% versus 15.1% p <0.001). Of the patients with M. tuberculosis bacteraemia, six were HIV negative or had no documentation of HIV status, including five with immunosuppressive conditions other than HIV. Patients with M. tuberculosis bacteraemia were more likely than patients with negative blood cultures to be deceased at diagnosis or to die while on TB therapy (50.0% versus 17.0%, p <0.01), to report men-who-have-sex-with-men behaviour (31.7% versus 13.0%, p 0.03), to have renal failure (28.6% versus 6.4%, p 0.01), and to have HIV RNA levels higher than 500 000 copies/mL (61.9% versus 17.2%, p ≤0.01). Requests for mycobacterial culture of blood specimens were more common in HIV-infected individuals, and the presence of M. tuberculosis bacteraemia was associated with a significant increase in mortality.
© 2013 The Authors Clinical Microbiology and Infection © 2013 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Human immunodeficiency virus; Mycobacterium tuberculosis bacteraemia; mortality; outcomes; tuberculosis

Mesh:

Substances:

Year:  2013        PMID: 23980760      PMCID: PMC4004024          DOI: 10.1111/1469-0691.12298

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  15 in total

1.  Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination.

Authors:  S Sreevatsan; X Pan; K E Stockbauer; N D Connell; B N Kreiswirth; T S Whittam; J M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Clinical indicators of mycobacteraemia in adults admitted to hospital in Blantyre, Malawi.

Authors:  D K Lewis; R P H Peters; M J Schijffelen; G R F Joaki; A L Walsh; J G Kublin; J Kumwenda; S Kampondeni; M E Molyneux; E E Zijlstra
Journal:  Int J Tuberc Lung Dis       Date:  2002-12       Impact factor: 2.373

3.  Mortality associated with central nervous system tuberculosis.

Authors:  Hana M El Sahly; Larry D Teeter; Xi Pan; James M Musser; Edward A Graviss
Journal:  J Infect       Date:  2007-10-17       Impact factor: 6.072

4.  Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study.

Authors:  Daria Podlekareva; Amanda Mocroft; Ulrik B Dragsted; Bruno Ledergerber; Marek Beniowski; Adriano Lazzarin; Jonathan Weber; Nathan Clumeck; Norbert Vetter; Andrew Phillips; Jens D Lundgren
Journal:  J Infect Dis       Date:  2006-07-24       Impact factor: 5.226

5.  Utility of blood cultures and incidence of mycobacteremia in patients with suspected tuberculosis in a South African infectious disease referral hospital.

Authors:  A von Gottberg; L Sacks; S Machala; L Blumberg
Journal:  Int J Tuberc Lung Dis       Date:  2001-01       Impact factor: 2.373

6.  Bacteremic disseminated tuberculosis in sub-saharan Africa: a prospective cohort study.

Authors:  John A Crump; Habib O Ramadhani; Anne B Morrissey; Wilbrod Saganda; Mtumwa S Mwako; Lan-Yan Yang; Shein-Chung Chow; Boniface N Njau; Godfrey S Mushi; Venance P Maro; L Barth Reller; John A Bartlett
Journal:  Clin Infect Dis       Date:  2012-04-16       Impact factor: 9.079

7.  Unrecognised Mycobacterium tuberculosis bacteraemia among hospital inpatients in less developed countries.

Authors:  L C McDonald; L K Archibald; S Rheanpumikankit; S Tansuphaswadikul; B Eampokalap; O Nwanyanawu; P Kazembe; H Dobbie; L B Reller; W R Jarvis
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

8.  Mycobacteremia in patients with the acquired immunodeficiency syndrome.

Authors:  B Grinsztejn; F C Fandinho; V G Veloso; E C João; M C Lourenço; S A Nogueira; L S Fonseca; E Werneck-Barroso
Journal:  Arch Intern Med       Date:  1997-11-10

9.  Mycobacterium tuberculosis bacteremia in patients with and without human immunodeficiency virus infection.

Authors:  E Bouza; M D Díaz-López; S Moreno; J C Bernaldo de Quirós; T Vicente; J Berenguer
Journal:  Arch Intern Med       Date:  1993-02-22

10.  Prevalence of mycobacteremia in Indian HIV-infected patients detected by the MB/BacT automated culture system.

Authors:  K Gopinath; S Kumar; S Singh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-10       Impact factor: 3.267

View more
  1 in total

1.  Mycobacterium tuberculosis complex bacteremia among HIV and non-HIV patients in a Mexican tertiary care center.

Authors:  Karla Maria Tamez-Torres; Pedro Torres-Gonzalez; Miguel E Cervera-Hernandez; Barbara Chavez-Mazari; Corazon de Jesus Barrientos-Flores; Miriam Bobadilla-Del-Valle; Alfredo Ponce-de-Leon; Jose Sifuentes-Osornio
Journal:  Braz J Infect Dis       Date:  2018-10-30       Impact factor: 3.257

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.